ARG1 and cancer: Exploration of this hotspot region identified a 38-aa peptide, ‘ArgLong2’, that activated frequent, strong, and spontaneous ARG1-specific T-cell responses in PBMC samples from heathy donors as well as cancer patients (20, 23).